Introducing
Osciflex

Osciflex system imitates nature’s process to prevent deadly blood clots.

Osciflex-DVT-Prevention-System-1_edited.png
Abstract Lines

Venous thromboembolism (VTE) is a leading cause of complication and death for hospitalized patients. Patients who sustain a VTE have approximately twice the length of stay and total inpatient cost as patients who do not.

Prevention of hospital associated VTE (HA-VTE) is a national priority.

>70% of ALL hospital patients are considered at risk.

There are 300,000-600,000 cases per year in the US, most in hospitals.

Approximately 1 in 5 patients are readmitted within 30 days.

This is the LEADING cause of preventable hospital deaths in the US (~100,000/year).

These clots cost the Healthcare System $7-$10 Billion annually in the U.S.